Overview

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
0
Participant gender:
Male
Summary
To determine the safety profile of Androxal in men with secondary hypogonadism.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Zuclomiphene
Criteria
Inclusion Criteria:

• Successful completion of either ZA-301 or ZA-302

Exclusion Criteria:

• Any condition which, in the opinion of the Investigator, would make the Subject an
unsuitable candidate for enrollment in the study